Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JB Chemicals and Pharmaceuticals is a diversified, India-headquartered pharmaceutical company with leading positions in gastrointestinal, cardiovascular, anti-infective, and chronic care markets. Its marquee brands, including cilnidipine (Cilacar), ranitidine (Rantac), and metronidazole (Metrogyl), are top-ranked nationally. It operates an extensive pipeline of branded products, generics (including 16 US ANDA approvals and a US generics business), and proprietary products, and maintains robust financial performance with double-digit YoY growth in 2023-2025. The company has recently been acquired by Torrent Pharmaceuticals in a major consolidation move[8][3][1][6][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JB Chemicals and Pharmaceuticals.